Posted in M&A / Deals Otsuka picks up PTSD drug with $700M Transcend buy March 27, 2026 BioPharma Dive The buyout, which includes another $525 million in floated payouts, hands Otsuka a medicine it sees as a possibly paradigm-shifting therapy in psychiatry. M&A / DealsNeuroscienceRead full story